1. Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.
- Author
-
Shukla, Navika D, Salahudeen, Ameen A, Taylor, Gregory A, Ramalingam, Suresh S, Vokes, Everett E, Goss, Glenwood D, Decker, Roy H, Kelly, Karen, Scagliotti, Giorgio V, Mok, Tony S, and Wakelee, Heather A
- Subjects
Humans ,Thoracic Neoplasms ,Prognosis ,Immunotherapy ,International Cooperation ,Clinical Trials as Topic ,Clinical trials ,Mesothelioma ,Non–small-cell lung cancer ,Small cell lung cancer ,Thymic carcinoma ,Non-small-cell lung cancer ,Lung ,Lung Cancer ,Cancer ,Clinical Sciences ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis - Abstract
Cancer cooperative groups have historically played a critical role in the advancement of non-small-cell lung cancer therapy. Representatives from cooperative groups worldwide convene at the International Lung Cancer Congress annually. The International Lung Cancer Congress had its 17th anniversary in the summer of 2016. The present review highlights the thoracic malignancy studies discussed by presenters. The included studies are merely a sample of the trials of thoracic malignancies ongoing globally.
- Published
- 2018